Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Más información
Título de la Revista: | Circulation |
Volumen: | 132 |
Asunto: | 8 |
Editorial: | Wolters Kluwer Health |
Fecha de publicación: | 2015 |
Página de inicio: | 624 |
Página final: | 632 |
DOI/URL: |
10.1161/CIRCULATIONAHA.114.014807 |